title: Postsurgical administration of estradiol benzoate decreases tensile strength of healing skin wounds in ovariectomized rats.
abstract: BACKGROUND
  The most effective method of increasing the level of estrogen in the wounds of post-menopausal women undergoing routine surgical procedures is by long-term preoperative administration. However, in the case of acute surgery or trauma, the most effective method of increasing the level of estrogen is administration immediately pre- or postsurgery. This study, therefore, was aimed at assessing the effect of postsurgical administration of estradiol benzoate on wound healing in ovariectomized (OVX) Sprague Dawley rats.
  
  
  METHODS
  Three months prior to the wound healing experiment, 16 rats were anesthetized and underwent ovariectomy, while the other eight rats were sham operated. Two parallel full thickness skin incisions and two round full thickness skin excisions were performed on the dorsum of each rat. Dose of 10 microg/d of estradiol benzoate was administered to eight OVX rats for 6 d postoperatively, whereas the other animals received a placebo. After 6 d, all animals were sacrificed and samples removed for biomechanical and histological evaluation.
  
  
  RESULTS
  The mean wound tensile strength of OVX estrogen treated rats (9.54 +/- 3.24 g/mm(2)) was significantly lower compared with vehicle-treated OVX animals (14.57 +/- 4.12 g/mm(2)) as well as with control rats subjected to sham-OVX surgery (11.71 +/- 3.33 g/mm(2)). Nevertheless, the histological evaluation in OVX estrogen treated rats showed a significantly increased process of neo-angiogenesis associated with slightly decreased collagen deposition.
  
  
  CONCLUSIONS
  Our results indicate that the question of the clinical significance of this type of hormone replacement therapy remains open and requires further research.
authors.affiliation: Department of Medical Biophysics, Faculty of Medicine, Pavol Jozef Safárik University, Kosice, Slovak Republic. galovci@yahoo.com
authors.forename: Peter
authors.initials: P
authors.lastname: Gál
authors.forename: Tomás
authors.initials: T
authors.lastname: Toporcer
authors.forename: Boris
authors.initials: B
authors.lastname: Vidinský
authors.forename: Michal
authors.initials: M
authors.lastname: Mokrý
authors.forename: Tomás
authors.initials: T
authors.lastname: Grendel
authors.forename: Martin
authors.initials: M
authors.lastname: Novotný
authors.forename: Ján
authors.initials: J
authors.lastname: Sokolský
authors.forename: Nikita
authors.initials: N
authors.lastname: Bobrov
authors.forename: Silvia
authors.initials: S
authors.lastname: Toporcerová
authors.forename: Ján
authors.initials: J
authors.lastname: Sabo
authors.forename: Stefan
authors.initials: S
authors.lastname: Mozes
mesh_terms: D000818:Animals; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D015914:Estrogen Replacement Therapy; D005260:Female; D010052:Ovariectomy; D011374:Progesterone / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000473:pathology; D013718:Tensile Strength; D014945:Wound Healing / Q000187:drug effects*
chemical_list: C074283:estradiol 3-benzoate; D011374:Progesterone; D004958:Estradiol